AGP Picks
View all

Vatican Technology Review
Provided by AGP

Vatican Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Technology Review.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 20, 2026

Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk
May 20, 2026

Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk

Indeterminate GlobeNewswire
23andMe Partners with HealthEx to Connect Medical Records with Your DNA for the Future of Personalized Medicine
May 20, 2026

23andMe Partners with HealthEx to Connect Medical Records with Your DNA for the Future of Personalized Medicine

Indeterminate GlobeNewswire
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
May 20, 2026

Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs

Indeterminate GlobeNewswire
ELECTRA AI to Present at Sidoti’s Micro-Cap Virtual Investor Conference Today and Tomorrow, May 20-21
May 20, 2026

ELECTRA AI to Present at Sidoti’s Micro-Cap Virtual Investor Conference Today and Tomorrow, May 20-21

Indeterminate GlobeNewswire
Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
May 20, 2026

Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting

Indeterminate GlobeNewswire
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
May 20, 2026

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

Indeterminate GlobeNewswire
XCHANGE ‘26 Attendee Insights Highlight Healthcare AI’s Shift From Adoption to Operational Scale
May 20, 2026

XCHANGE ‘26 Attendee Insights Highlight Healthcare AI’s Shift From Adoption to Operational Scale

Indeterminate GlobeNewswire
Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants
May 20, 2026

Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants

Indeterminate GlobeNewswire
Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval
May 20, 2026

Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval

Indeterminate GlobeNewswire
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
May 20, 2026

Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform
May 20, 2026

Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform

Indeterminate GlobeNewswire
Rail Vision: Quantum Transportation Successfully Integrates Google’s Public Surface-Code Dataset into its Quantum Error Correction Transformer
May 20, 2026

Rail Vision: Quantum Transportation Successfully Integrates Google’s Public Surface-Code Dataset into its Quantum Error Correction Transformer

Indeterminate GlobeNewswire
Quantum Cyber Files Provisional Patent for Quantum-Navigated Amphibious Autonomous Ground Vehicle Platform
May 20, 2026

Quantum Cyber Files Provisional Patent for Quantum-Navigated Amphibious Autonomous Ground Vehicle Platform

Indeterminate GlobeNewswire
Luciphia Launches Cooling Mat to Keep Pets Cool and Comfortable This Summer
May 20, 2026

Luciphia Launches Cooling Mat to Keep Pets Cool and Comfortable This Summer

Indeterminate GlobeNewswire
EC-Council Releases Certified CISO Hall of Fame 2025 Report, Defining the Rise of the AI-Era Cybersecurity Executive
May 20, 2026

EC-Council Releases Certified CISO Hall of Fame 2025 Report, Defining the Rise of the AI-Era Cybersecurity Executive

Indeterminate GlobeNewswire
Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report
May 20, 2026

Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report

Indeterminate GlobeNewswire
KANZHUN LIMITED Announces First Quarter 2026 Financial Results
May 20, 2026

KANZHUN LIMITED Announces First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
The Cost of a Power Bank Fire Could Be More Than Just One Damaged Device: Meenova SolidPower Semi-Solid Battery Power Banks Launch on Kickstarter
May 20, 2026

The Cost of a Power Bank Fire Could Be More Than Just One Damaged Device: Meenova SolidPower Semi-Solid Battery Power Banks Launch on Kickstarter

Indeterminate GlobeNewswire
GDS Announces Resignation and Appointment of Independent Director and Audit Committee Chair
May 20, 2026

GDS Announces Resignation and Appointment of Independent Director and Audit Committee Chair

Indeterminate GlobeNewswire
4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial
May 20, 2026

4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Vatican Technology Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.